Cardiovascular Analysis

STAT Supreme Court backs generic drugmaker in 'skinny labeling' case: Implications for pharma BD and investors

Supreme Court · 6 min

Kardigan's IPO Plans: Fueling the Next Wave of Cardiovascular Drug Development

heart disease · 7 min

Mounjaro FDA Approval Obesity: Eli Lilly's Tirzepatide Awaits

FDA · obesity, cardiovascular outcomes · 13 min

SURPASS-CVOT Trial Results: Implications for Mounjaro's Cardiovascular Safety and FDA Labeling

FDA · Type 2 Diabetes · 6 min

FDA Approval of Elarekibart: Current Status and Market Implications

FDA · treatment-resistant hypertension · 8 min

FDA Approval of Sotatercept: Market Impact and Clinical Outlook for Winrevair

FDA · pulmonary arterial hypertension · 8 min